Stock COSMO PHARMACEUTICALS S.P.A
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Cosmo Pharmaceuticals S.p.A Swiss Exchange

Equities

IT0004167463

End-of-day quote Swiss Exchange
Other stock markets
- CHF - Intraday chart for Cosmo Pharmaceuticals S.p.A
04-26 Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 CI
04-25 Cosmo Pharmaceuticals Names New CEO, Chairman MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cosmo Reports Excellent Final Full Year 2023 Financial Results - Increases Operating Profit Guidance for 2024 - Dividend of 2.00 per Share Will Be Proposed at EGM on 5 July 2024
NE
Cosmo Pharmaceuticals N : reports excellent final Full Year 2023 financial results – Increases operating profit guidance for 2024 – Dividend of € 2.00 per share will be proposed at EGM on 5 July 2024
PU
Cosmo Pharmaceuticals' Shareholders Approve All Agenda Items at Annual General Meeting
NE
Cosmo Pharmaceuticals N : ’ Shareholders approve all Agenda Items at Annual General Meeting
PU
Cosmo Pharmaceuticals N : Niall Donnelly CV
PU
Cosmo Pharmaceuticals N : Convening notice
PU
Cosmo Pharmaceuticals N : Written Proxy
PU
Cosmo Pharmaceuticals N : Explanatory notes
PU
Cosmo Pharmaceuticals N : Notification of number of shares
PU
Cosmo Pharmaceuticals N : Alessandro Della Chà CV
PU
Cosmo Pharmaceuticals N : Giovanni Di Napoli CV
PU
Cosmo Pharmaceuticals N : John O’Dea CV
PU
Cosmo Pharmaceuticals N : Maria Grazie Roncarolo CV
PU
Cosmo Pharmaceuticals N : Mauro S. Ajani CV
PU
Cosmo Pharmaceuticals N : Nail Donnely CV
PU
Cosmo Has Received Approval of an Extension in Respect of the Publication and the Filing of Its Annual Report 2023
NE
Cosmo Pharmaceuticals N : has received approval of an extension in respect of the publication and the filing of its annual report 2023
PU
Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024
CI
Cosmo Pharmaceuticals Names New CEO, Chairman
MT
Cosmo Announces Leadership Changes
NE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. COPN Stock
  4. Stock
  5. News Cosmo Pharmaceuticals S.p.A